Results 171 to 180 of about 2,696,596 (307)
Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor types
Background Insulin-like growth factor 2 (IGF2) mRNA-binding proteins 2 (IGF2BP2/IMP2), an RNA-binding protein encoded by the IGF2BP2 gene, exerts its influence across diverse pathological pathways.
Hong-Lu Zhou, Dan-Dan Chen, Xiu-Ling Li
doaj +1 more source
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu +12 more
wiley +1 more source
Availability and reimbursement of biological products for severe asthma in Bulgaria. [PDF]
Milushewa P, Doneva M, Petrova G.
europepmc +1 more source
Quality assurance of monoclonal products: Virologic and molecular biologic considerations [PDF]
Daniel L. Prince, Richard N. Prince
openalex +1 more source
This study investigates gene expression differences between two major pediatric acute lymphoblastic leukemia (ALL) subtypes, B‐cell precursor ALL, and T‐cell ALL, using a data‐driven approach consisting of biostatistics and machine learning methods. Following analysis of a discovery dataset, we find a set of 14 expression markers differentiating the ...
Mona Nourbakhsh +8 more
wiley +1 more source
Comparability Considerations and Challenges for Expedited Development Programs for Biological Products. [PDF]
Schrieber SJ +8 more
europepmc +1 more source
A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization. [PDF]
Robert L. Coffman +4 more
openalex +1 more source
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo +8 more
wiley +1 more source
On the Response of the Bacterial Carrier, Guinea Pigs in the Safety Test of Biological Products
Kiichi Horie +5 more
openalex +2 more sources
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source

